The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 17, 2023
Filed:
Mar. 13, 2019
Applicant:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Jiangsu, CN;
Inventors:
Xin Tian, Jiangsu, CN;
Peng Lv, Jiangsu, CN;
Ling Yang, Jiangsu, CN;
Xiangjian Wang, Jiangsu, CN;
Xiquan Zhang, Jiangsu, CN;
Shanchun Wang, Jiangsu, CN;
Xunqiang Wang, Jiangsu, CN;
Hai Jiang, Jiangsu, CN;
Assignee:
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD., Jiangsu, CN;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4709 (2006.01); A61P 35/00 (2006.01); A61K 33/243 (2019.01); A61K 9/00 (2006.01); A61K 31/337 (2006.01); A61K 31/675 (2006.01); A61K 31/704 (2006.01); A61K 31/7068 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4709 (2013.01); A61K 9/0053 (2013.01); A61K 31/337 (2013.01); A61K 31/675 (2013.01); A61K 31/704 (2013.01); A61K 31/7068 (2013.01); A61K 33/243 (2019.01); A61P 35/00 (2018.01);
Abstract
The present invention provides a quinoline derivative for treating triple-negative breast cancer and use thereof in preparing a pharmaceutical composition for treating a tumor. Specifically, the present invention relates to use of quinoline derivative 1-[[[4-(4-fluoro-2-methyl-1H-indol-5-yl)oxy-6-methoxyquinoline-7-yl]oxy]methyl]cyclopropylamine in the treatment of triple-negative breast cancer,